| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.148 | 47.936 | 47.230 | 63.301 | 59.146 | 17.262 | 55.879 | 59.491 | 58.785 | 86.243 |
| Total Income - EUR | 47.959 | 48.636 | 47.230 | 63.301 | 69.688 | 17.262 | 63.833 | 68.918 | 303.041 | 88.084 |
| Total Expenses - EUR | 33.544 | 45.801 | 36.226 | 72.151 | 61.387 | 14.492 | 56.344 | 64.458 | 190.063 | 124.075 |
| Gross Profit/Loss - EUR | 14.415 | 2.835 | 11.004 | -8.851 | 8.301 | 2.770 | 7.489 | 4.460 | 112.977 | -35.991 |
| Net Profit/Loss - EUR | 12.976 | 1.376 | 8.717 | -9.484 | 7.604 | 2.540 | 6.941 | 3.894 | 110.011 | -35.991 |
| Employees | 2 | 1 | 2 | 2 | 2 | 1 | 4 | 4 | 3 | 2 |
Check the financial reports for the company - Europrecepta Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 596 | 9.650 | 10.606 | 131.562 | 131.268 | 127.593 | 122.611 | 119.056 | 22.477 | 18.210 |
| Current Assets | 5.899 | 7.425 | 11.094 | 4.922 | -26 | 1.887 | 231 | 472 | 108.487 | 678 |
| Inventories | 3.936 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 109 | 0 | 1.812 | 0 | 0 | 46.070 | 400 |
| Cash | 1.963 | 7.425 | 11.094 | 4.813 | -26 | 75 | 231 | 472 | 62.417 | 277 |
| Shareholders Funds | 1.306 | 2.669 | 11.340 | 1.648 | 9.221 | 11.585 | 18.270 | 22.220 | 110.060 | 16.343 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.189 | 14.406 | 10.359 | 134.970 | 120.224 | 118.301 | 107.733 | 97.051 | 20.905 | 2.545 |
| Income in Advance | 0 | 0 | 0 | 0 | 2.276 | 0 | 658 | 257 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Europrecepta Srl